Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amniotic Membrane Patch for Postoperative Atrial Fibrillation in CABG
NCT02193321Phase 2Withdrawn
- Sponsor
- University of Arizona
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of PalinGen KardiaMembrane in Atrial fibrillation (AFib), sponsored by University of Arizona. Planned start Jul 2014; status: withdrawn.
02
Drugs
PalinGen KardiaMembrane
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02193321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193321.